Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

40.12 -1.16 (-2.80%)
Streaming Delayed Price Updated: 9:59 AM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 877,161
Open 40.30
Bid (Size) 40.09 (4)
Ask (Size) 40.20 (5)
Prev. Close 41.27
Today's Range 39.94 - 41.31
52wk Range 18.92 - 81.73
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst
William Blair projects strong VENTURE-Oral trial results for Viking's VK2735, citing flexibility and market opportunity after a rival's setback. 
Via Benzinga
The 3 Things That Matter for Viking Therapeutics Now
Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations. 
Via The Motley Fool

Performance

YTD
-2.4%
-2.4%
1 Month
+26.8%
+26.8%
3 Month
+51.0%
+51.0%
6 Month
+36.8%
+36.8%
1 Year
-28.6%
-28.6%

More News

Read More
If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Eli Lilly Stock Marks Worst Day In 25 Years As Weight-Loss Pill Data Disappoints: Analysts Divided But Retail Bets On Rebound
Via Stocktwits
Eli Lilly Shares Tumble After Disappointing Weight-Loss Pill Data
Via MarketMinute
Earnings Scheduled For July 23, 2025
Via Benzinga
A Look Ahead: Viking Therapeutics's Earnings Forecast
Via Benzinga
Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations
Via MarketMinute
Topics Economy
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors
Via Benzinga
Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge.
Via Investor's Business Daily
Is It Time to Buy Biotech Stocks?
Via The Motley Fool
This Biotech Stock Could Soar on Upcoming Clinical Data
Via The Motley Fool
2 Beaten-Down Stocks With Incredible Upside Potential
Via The Motley Fool
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts
Via The Motley Fool
Is Viking Therapeutics the Next Big Biotech Bet?
Via The Motley Fool
Benzinga Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare — And Trade Deal Optimism Boosts Markets
Via Benzinga
Tesla Posts Downbeat Earnings, Joins Community Health Systems, Chipotle Mexican Grill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Viking Therapeutics Posts Wider Q2 Loss
Via The Motley Fool
Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates
Via Benzinga
Viking (VKTX) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Viking Therapeutics Inc (NASDAQ:VKTX) Posts Wider Q2 2025 Loss, Shares Drop in After-Hours Trading
Via Chartmill
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
Via The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
Via The Motley Fool
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
Via The Motley Fool

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 40.12
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 08/14/25 09:59 AM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.99B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.